
Precision Molecular Pathology of Myeloid Neoplasms
Springer (Publisher)
Published on 26. August 2018
Book
Paperback/Softback
XI, 427 pages
978-3-319-87241-4 (ISBN)
Description
This volume provides a comprehensive, state-of-the art review of myeloid neoplasms. The book presents updated information on epidemiology, clinical presentation, morphologic findings, molecular genomic abnormalities, pathogenesis, and target therapies. The text helps to guide accurate diagnosis, the administration of appropriate ancillary molecular tests, patient management, and investigative efforts. The book also includes over 200 illustrations, photographs, and tables.
Written by experts in the field, Precision Molecular Pathology of Myeloid Neoplasms serves as a valuable resource for pathologists, hematologists/oncologists, fellows, and researchers in understanding the molecular pathology of myeloid neoplasms.
Written by experts in the field, Precision Molecular Pathology of Myeloid Neoplasms serves as a valuable resource for pathologists, hematologists/oncologists, fellows, and researchers in understanding the molecular pathology of myeloid neoplasms.
More details
Series
Edition
Softcover Reprint of the Original 1st 2018 ed.
Language
English
Place of publication
Cham
Switzerland
Publishing group
Springer International Publishing
Target group
Professional and scholarly
Illustrations
66 farbige Abbildungen, 18 s/w Abbildungen
XI, 427 p. 84 illus., 66 illus. in color.
Dimensions
Height: 235 mm
Width: 155 mm
Thickness: 23 mm
Weight
755 gr
ISBN-13
978-3-319-87241-4 (9783319872414)
DOI
10.1007/978-3-319-62146-3
Schweitzer Classification
Other editions
Additional editions

Chung-Che (Jeff) Chang | Robert S. Ohgami
Precision Molecular Pathology of Myeloid Neoplasms
Book
10/2017
Springer
€213.99
Shipment within 10-15 days
Persons
Chung-Che (Jeff) Chang, MD, PhDProfessor of PathologyUniversity of Central Florida;Medical Director, Hematology and Molecular Pathology LabsFlorida HospitalOrlando, Florida
Robert S. Ohgami, MD, PhDAssistant Professor of PathologyAssociate Program Director for Anatomic PathologyDepartment of PathologyStanford UniversityStanford, California
Robert S. Ohgami, MD, PhDAssistant Professor of PathologyAssociate Program Director for Anatomic PathologyDepartment of PathologyStanford UniversityStanford, California
Content
Acute myeloid leukemia (AML) with recurrent cytogenetic abnormalities.- AML with characteristic molecular mutations: RUNX1, CEPA, NPM1, etc.- AML, NOS/AML with dysplasia-related changes/therapy-related myeloid neoplasm.- Myelodysplastic syndromes (MDS).- Chronic myelogenous leukemia (CML).- Polythesemia vera (PV).- Essential thrombocythemia (ET).- Primary myelofibrosis (PMF).- Mastocytosis.- Myeloproliferative neoplasms (MPN), rare types (Chronic eosinophilic leukemia, Chronic neutrophilic leukemia).- Atypical CML.- Chronic myelomonocytic leukemia (CMML).- Juvenile myelomonocytic leukemia (JMML).- Childhood MDS.- Familial AML/MPN/MDS.- Myeloid and lymphoid neoplasm with eosinophilia and abnormalities of PDGFRA, PDGFRB, or FGFR1.